| Literature DB >> 27924169 |
Scott O'Keefe1, Kenneth Williams1, Jean-Francois Legare1.
Abstract
BACKGROUND: The management of hospital-acquired infections (HAIs) with respect to physician practices remains largely unexplored despite increasing efforts to standardize care. In the present study, we report findings from a 2-month audit of all patients that have undergone cardiac surgery at a large referral center in Atlantic Canada.Entities:
Keywords: Antimicrobial stewardship; Hospital-acquired infection; Infection verification
Year: 2016 PMID: 27924169 PMCID: PMC5127209 DOI: 10.14740/jocmr2637w
Source DB: PubMed Journal: J Clin Med Res ISSN: 1918-3003
Preoperative Clinical Characteristics
| Characteristics | Infection cases | P value | |
|---|---|---|---|
| Yes, n = 39 (%) | No, n = 146 (%) | ||
| Age (years) | 0.0185 | ||
| < 60 | 7 (17.9) | 54 (37.0) | |
| 60 - 69 | 12 (30.8) | 51 (34.9) | |
| 70 - 79 | 14 (35.9) | 23 (15.8) | |
| ≥ 80 | 6 (15.4) | 18 (12.3) | |
| Female | 7 (17.9) | 32 (21.9) | n/s |
| EF < 40% | 6 (15.4) | 14 (9.6) | n/s |
| PVD and/or CVD | 15 (38.5) | 47 (32.2) | n/s |
| Renal insufficiency (Cr > 176) | 4 (10.3) | 10 (6.8) | n/s |
| Diabetes | 13 (33.3) | 39 (26.7) | n/s |
| CHF | 5 (10.2) | 14 (9.6) | n/s |
| COPD | 7 (17.5) | 16 (11.0) | n/s |
| Redo surg. | 1 (2.6) | 11 (7.5) | n/s |
| Procedure type | n/s | ||
| Isol. CABG | 20 (51.3) | 76 (52.1) | |
| Isol. valve | 5 (12.8) | 29 (19.9) | |
| CABG + valve | 6 (15.4) | 10 (6.8) | |
| Complex procedure | 8 (20.5) | 31 (21.2) | |
| Status | n/s | ||
| Elective | 14 (35.9) | 76 (52.1) | |
| In-house | 22 (56.4) | 60 (41.1) | |
| Urgent (< 4 h) | 2 (5.1) | 7 (4.8) | |
| Emergency | 1 (2.6) | 3 (2.1) | |
| NYHA class | n/s | ||
| I | 1 (2.9) | 15 (12.3) | |
| II | 11 (32.4) | 39 (32.0) | |
| III | 19 (55.9) | 51 (41.9) | |
| IV | 3 (8.8) | 17 (13.9) | |
CABG: coronary artery bypass graft; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; Cr: creatinine; CVD: cerebral vascular disease; EF: ejection fraction; Isol: isolated; NYHA: New York Heart Association; PVD: peripheral vascular disease; n/s: not significant.
Unadjusted Postoperative Outcomes
| Outcome | Infection cases | P value | |
|---|---|---|---|
| Yes, n = 39 (%) | No, n = 146 (%) | ||
| Mortality | 4 (10.3) | 3 (2.1) | 0.0369 |
| LOS > 9 days | 28 (71.8) | 50 (34.2) | < 0.0001 |
| Infection type | |||
| UTI | 14 (35.9) | - | |
| Pneumonia | 12 (30.8) | - | |
| Leg harvest site | 9 (23.1) | - | |
| sSSI | 8 (20.5) | - | |
| Sepsis | 3 (7.7) | - | |
LOS: length of stay; sSSI: superficial surgical site infection; UTI: urinary tract infection.
Figure 1Total number of infections treated vs. confirmed with positive lab cultures. UTI: urinary tract infection; LegInf: leg infection; InfStSup: superficial surgical site infection.
Figure 2Mean time until infection was detected starting from the time of surgery. InfStSup: superficial surgical site infection; UTI: urinary tract infection; LegInf: leg infection.
Verified Microbiology Cultures
| Infection type | Organism | Cases |
|---|---|---|
| UTI | 7 | |
| 2 | ||
| 1 | ||
| 1 | ||
| 1 | ||
| 1 | ||
| 1 | ||
| Pneumonia | 3 | |
| 2 | ||
| 1 | ||
| 1 | ||
| 1 | ||
| 1 | ||
| 1 | ||
| 1 | ||
| Leg harvest site | Cellulitis*** | 1 |
| sSSI | Coagulase-negative | 2 |
| Sepsis | 2 | |
| Coagulase-negative | 1 |
sSSI: superficial surgical site infection; UTI: urinary tract infection.
Figure 3Median duration of antimicrobial treatment. InfStSup: superficial surgical site infection; LegInf: leg infection; UTI: urinary tract infection.